153 related articles for article (PubMed ID: 37256498)
1. Anticonvulsant Role of Adenosine is Blunted During Alcohol Withdrawal Syndrome in an Adult Zebrafish Model.
Couto GT; da Silva GP; Rockenbach L; da Silva JS; Vianna MRMR; Da Silva RS
Neurochem Res; 2023 Oct; 48(10):3007-3015. PubMed ID: 37256498
[TBL] [Abstract][Full Text] [Related]
2. Chronic ethanol intoxication enhances [3H]CCPA binding and does not reduce A1 adenosine receptor function in rat cerebellum.
Concas A; Mascia MP; Cuccheddu T; Floris S; Mostallino MC; Perra C; Satta S; Biggio G
Pharmacol Biochem Behav; 1996 Feb; 53(2):249-55. PubMed ID: 8808128
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome.
Kaplan GB; Bharmal NH; Leite-Morris KA; Adams WR
Alcohol; 1999 Oct; 19(2):157-62. PubMed ID: 10548160
[TBL] [Abstract][Full Text] [Related]
4. 2-Chloro-N6-cyclopentyladenosine (CCPA), an adenosine A1 receptor agonist, suppresses ethanol withdrawal syndrome in rats.
Concas A; Cuccheddu T; Floris S; Mascia MP; Biggio G
Alcohol Alcohol; 1994 May; 29(3):261-4. PubMed ID: 7945566
[TBL] [Abstract][Full Text] [Related]
5. Single and repeated episodes of ethanol withdrawal increase adenosine A1, but not A2A, receptor density in mouse brain.
Jarvis MF; Becker HC
Brain Res; 1998 Mar; 786(1-2):80-8. PubMed ID: 9554962
[TBL] [Abstract][Full Text] [Related]
6. The kindling model of alcohol dependence: similar persistent reduction in seizure threshold to pentylenetetrazol in animals receiving chronic ethanol or chronic pentylenetetrazol.
Kokka N; Sapp DW; Taylor AM; Olsen RW
Alcohol Clin Exp Res; 1993 Jun; 17(3):525-31. PubMed ID: 8392817
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.
Beadles-Bohling AS; Wiren KM
Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153
[TBL] [Abstract][Full Text] [Related]
8. Functioning and Gene Expression of Adenosine A
Couto GT; Caetano HA; da Silva GP; Rockenbach L; Silva JSD; Vianna MR; Da Silva RS
Zebrafish; 2023 Oct; 20(5):210-220. PubMed ID: 37856674
[TBL] [Abstract][Full Text] [Related]
9. Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice.
Listos J; Malec D; Fidecka S
Eur J Pharmacol; 2005 Oct; 523(1-3):71-8. PubMed ID: 16226742
[TBL] [Abstract][Full Text] [Related]
10. Influence of adenosinergic drugs on ethanol withdrawal syndrome in rats.
Malec D; Michalska E; Pikulicka J
Pol J Pharmacol; 1996; 48(6):583-8. PubMed ID: 9112697
[TBL] [Abstract][Full Text] [Related]
11. Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats.
Cagetti E; Baicy KJ; Olsen RW
Neuroreport; 2004 Jan; 15(1):207-10. PubMed ID: 15106859
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.
Concas A; Santoro G; Mascia MP; Maciocco E; Dazzi L; Ongini E; Biggio G
J Pharmacol Exp Ther; 1993 Nov; 267(2):844-51. PubMed ID: 8246158
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of ethanol withdrawal signs in the rat to gamma-aminobutyric acid (GABA)mimetics: blockade of audiogenic seizures but not forelimb tremors.
Frye GD; McCown TJ; Breese GR
J Pharmacol Exp Ther; 1983 Sep; 226(3):720-5. PubMed ID: 6310080
[TBL] [Abstract][Full Text] [Related]
14. Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal.
Riegle MA; Masicampo ML; Shan HQ; Xu V; Godwin DW
Alcohol Alcohol; 2015 Sep; 50(5):501-8. PubMed ID: 25870316
[TBL] [Abstract][Full Text] [Related]
15. Activation of adenosine A1 receptors reduces anxiety-like behavior during acute ethanol withdrawal (hangover) in mice.
Prediger RD; da Silva GE; Batista LC; Bittencourt AL; Takahashi RN
Neuropsychopharmacology; 2006 Oct; 31(10):2210-20. PubMed ID: 16407902
[TBL] [Abstract][Full Text] [Related]
16. Role of adenosine signaling on pentylenetetrazole-induced seizures in zebrafish.
Siebel AM; Menezes FP; Capiotti KM; Kist LW; da Costa Schaefer I; Frantz JZ; Bogo MR; Da Silva RS; Bonan CD
Zebrafish; 2015 Apr; 12(2):127-36. PubMed ID: 25560904
[TBL] [Abstract][Full Text] [Related]
17. Decreased anticonvulsant efficacy of allopregnanolone during ethanol withdrawal in female Withdrawal Seizure-Prone vs. Withdrawal Seizure-Resistant mice.
Beckley EH; Fretwell AM; Tanchuck MA; Gililland KR; Crabbe JC; Finn DA
Neuropharmacology; 2008 Feb; 54(2):365-74. PubMed ID: 18045626
[TBL] [Abstract][Full Text] [Related]
18. Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Capasso A; Gallo C
Curr Drug Saf; 2009 May; 4(2):97-102. PubMed ID: 19442100
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures.
Li M; Kang R; Shi J; Liu G; Zhang J
PLoS One; 2013; 8(6):e67060. PubMed ID: 23825618
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.
Abulseoud OA; Camsari UM; Ruby CL; Kasasbeh A; Choi S; Choi DS
Neuropsychopharmacology; 2014 Jun; 39(7):1674-84. PubMed ID: 24452391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
